Charles Pollack | Principal
CGP Consulting, PC

Charles Pollack, Principal, CGP Consulting, PC

Dr. Charles Pollack is a Clinician-Scientist with an academic appointment in the Department of Emergency Medicine at the University of Mississippi School of Medicine.  He has long been active in teaching and clinical research and is an international leader in emergency medicine. He is the only physician to have received the American College of Emergency Physicians’ highest national awards in both teaching and research; he also received the national teaching award from the Council of Emergency Medicine Residency Directors. He was the first US emergency physician to be elected a Fellow of the European Society of Cardiology. His primary research interests are in the management of thrombosis, reversal of antithrombotic therapy, and other aspects of urgent, emergent, and critical care.   As a trialist, principal investigator, Executive/Steering Committee chair and member, a DSMB chair and member, and as a trial medical monitor, Dr. Pollack has remarkably broad expertise in clinical trial design and execution, in human subjects protection, and in appropriate study oversight.  As Associate Chair of the IRB at Maricopa Medical Center for six years and as Co-Chair of IRB #6 at UPenn for 12 years, Dr Pollack also has accrued vast experience with IRB processes, regulatory and ethical expertise, and an unwavering commitment to protecting the rights and welfare of human research participants, including the ability to represent participant interests during board discussions.   From 2015-2019, Dr. Pollack served as Associate Provost at Thomas Jefferson University, where he was also Professor and Senior Advisor for Interdisciplinary Research and Clinical Trials, Department of Emergency Medicine.  From 2001-2015, Dr. Pollack was Professor of Emergency Medicine at the Perelman School of Medicine of the University of Pennsylvania and served as Chairman of Emergency Medicine at Pennsylvania Hospital in Philadelphia. From 1992-2001, Dr. Pollack served in various positions in the Department of Emergency Medicine at Maricopa Medical Center in Phoenix, Arizona, an urban, tertiary care teaching hospital affiliated with the Medical College of the University of Arizona and the Mayo Graduate School of Medicine. He was Research Director from 1994 to 2000, and he chaired the department from 1997 to 2001. From 2000 through mid-2001, Dr. Pollack was also Director of Emergency Medicine at Arizona Heart Hospital.   Dr. Pollack graduated summa cum laude from Emory University in 1980 with bachelor’s degrees in history and chemistry and with a master’s degree in the history of science and medicine.  He was elected to Phi Beta Kappa. Dr. Pollack earned his medical degree from Tulane University School of Medicine and is a member of Alpha Omega Alpha.   Dr. Pollack has written more than 500 original research articles, chapters, and abstracts, and serves on the editorial boards of several journals and on the steering committees of multiple national and international studies. He is a strong advocate for entrepreneurism and innovation in healthcare, and is passionate about addressing social inequality and access barriers in medicine. Dr. Pollack served two terms as Chair of the Board of Trustees of the University of Mississippi Medical Research Foundation, where inequity in healthcare is a paramount concern. 

Appearances:



Day 1 - World Drug Safety Congress Americas 2025 @ 12:20

Panel: Patient Safety Considerations in High-Risk Therapeutic Innovation: CV and Rare Disease in Focus

Join Dr. David Chonzi, Charles Pollack, and Dr. Ricardo Velazquez for an in-depth panel discussion on the evolving landscape of safety in the development of high-risk therapies, with particular emphasis on cardiovascular and rare disease indications. This session will delve into key challenges such as early safety signal detection, rigorous benefit-risk assessment, and the intricacies of clinical trial design—especially in the context of cutting-edge modalities like gene and RNA-based therapies.

Drawing on real-world examples and current regulatory frameworks, the panel will highlight how safety strategies are adapting to match the pace of scientific innovation. Attendees will come away with actionable insights into proactive safety planning across complex, high-stakes clinical development programs.

Sponsored by Clinigen.

last published: 16/Oct/25 00:25 GMT

back to speakers

Get Involved At Drug Safety Congress Americas

 

CONNECT WITH US

 

To Sponsor

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

Annabelle Pearson
Annabelle.Pearson@terrapinn.com

 

To Speak

Kaylee Nguyen
kaylee.nguyen@terrapinn.com

 

Marketing & Press

Karolina Bzikot
karolina.bzikot@terrapinn.com